
Sign up to save your podcasts
Or
David Liew interviews Dr Paul Kubler on the pros and cons of fast-tracked approvals for new drugs – does it save patients or put their safety at risk?
4.5
1313 ratings
David Liew interviews Dr Paul Kubler on the pros and cons of fast-tracked approvals for new drugs – does it save patients or put their safety at risk?
752 Listeners
132 Listeners
867 Listeners
532 Listeners
92 Listeners
21 Listeners
33 Listeners
316 Listeners
134 Listeners
51 Listeners
19 Listeners
250 Listeners
5 Listeners
63 Listeners
10 Listeners